Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10597743rdf:typepubmed:Citationlld:pubmed
pubmed-article:10597743lifeskim:mentionsumls-concept:C0041400lld:lifeskim
pubmed-article:10597743lifeskim:mentionsumls-concept:C0024305lld:lifeskim
pubmed-article:10597743lifeskim:mentionsumls-concept:C1514474lld:lifeskim
pubmed-article:10597743lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:10597743lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:10597743lifeskim:mentionsumls-concept:C1517067lld:lifeskim
pubmed-article:10597743pubmed:issue6lld:pubmed
pubmed-article:10597743pubmed:dateCreated1999-12-23lld:pubmed
pubmed-article:10597743pubmed:abstractTextClinical, histopathologic, and prognostic features of 114 patients with primary extranodal non-Hodgkin's lymphoma were evaluated. Median age of the patients was 48 (range, 15-76) and the ratio of male/female was 55/59. Thirty-seven patients had stage 1, 55 patients stage II, 6 patients stage III, and 16 patients stage IV. The most common sites of primary extranodal non-Hodgkin's lymphoma were the gastrointestinal (GI) tract and head-neck region. Stomach (66%) and tonsils (33%) were the most frequently involved organ in GI tract and head-neck region, respectively. Eighty percent of patients had intermediate or high-grade lymphomas, 20% had low-grade subtypes. Complete remission was achieved in 83% of all patients with chemotherapy +/- radiotherapy +/- surgery. Overall and disease-free survival at 5 years were 63% and 59%, respectively. In conclusion, clinical and histopathologic characteristics and prognosis of our cases with primary extranodal non-Hodgkin's lymphoma were usually similar to those of the cases in Western countries with some differences in the incidence of some specific primary extranodal non-Hodgkin's lymphomas and in the histopathologic subtypes.lld:pubmed
pubmed-article:10597743pubmed:languageenglld:pubmed
pubmed-article:10597743pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10597743pubmed:citationSubsetIMlld:pubmed
pubmed-article:10597743pubmed:statusMEDLINElld:pubmed
pubmed-article:10597743pubmed:monthDeclld:pubmed
pubmed-article:10597743pubmed:issn0277-3732lld:pubmed
pubmed-article:10597743pubmed:authorpubmed-author:CauJJlld:pubmed
pubmed-article:10597743pubmed:authorpubmed-author:IçliFFlld:pubmed
pubmed-article:10597743pubmed:authorpubmed-author:DemirkazikAAlld:pubmed
pubmed-article:10597743pubmed:authorpubmed-author:DinçolDDlld:pubmed
pubmed-article:10597743pubmed:authorpubmed-author:MoonS BSBlld:pubmed
pubmed-article:10597743pubmed:authorpubmed-author:AricanAAlld:pubmed
pubmed-article:10597743pubmed:authorpubmed-author:AkbulutHHlld:pubmed
pubmed-article:10597743pubmed:issnTypePrintlld:pubmed
pubmed-article:10597743pubmed:volume22lld:pubmed
pubmed-article:10597743pubmed:ownerNLMlld:pubmed
pubmed-article:10597743pubmed:authorsCompleteYlld:pubmed
pubmed-article:10597743pubmed:pagination587-92lld:pubmed
pubmed-article:10597743pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:meshHeadingpubmed-meshheading:10597743...lld:pubmed
pubmed-article:10597743pubmed:year1999lld:pubmed
pubmed-article:10597743pubmed:articleTitleClinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey.lld:pubmed
pubmed-article:10597743pubmed:affiliationDepartment of Medical Oncology, Ba?kent University, Faculty of Medicine, Ankara, Turkey.lld:pubmed
pubmed-article:10597743pubmed:publicationTypeJournal Articlelld:pubmed